Document is current
Any future updates will be listed below
-
Authors
Castello, Angelo
Rimassa, Lorenza
Personeni, Nicola
Pressiani, Tiziana
Smiroldo, Valeria
Lopci, Egesta https://orcid.org/0000-0001-9732-1094
- License Information
-
More Information
Article History
First Online: 23 March 2020
Compliance with Ethical Standards
:
: Personeni N. has received lecture fees from AbbVie and Gilead, and travel expenses from ArQule. Rimassa L. has received consulting fees from Lilly, Bayer, Sirtex Medical, ArQule, Exelixis, Ipsen, Celgene, Eisai, and Roche, lecture fees from AstraZeneca, AbbVie, and Gilead, and travel expenses from ArQule and Ipsen. Lopci E. declares royalties from Springer and lecture fees from ESMIT and MI&T S.r.l. The other authors have declared no conflict of interest.
: The trial has been approved by the ethics committee of Humanitas Clinical and Research Hospital. The trial has been registered at(NCT02977754).The protocol has been conducted in accordance with the ethical standards of the institutional and/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: All patients have signed an informed consent form before inclusion.
